Paydirt
MLYS
Ticker

Mineralys Therapeutics, Inc.

MLYS · Healthcare · Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the…

Mineralys Therapeutics, Inc. (MLYS), in the Healthcare sector, has 28 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 1 purchase and 27 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 30 and filed Oct 2. The most active filer was David Malcom Rodman with 10 filings. Data as of Nov 7 2026.

Add to watchlist
Filings, ttm
28
1 buy · 27 sells
Traders, ttm
8
8 insiders
Volume, ttmiDollar value disclosed in the window
$35.7M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 30
Filed Oct 2
ADViAverage daily dollar volume
$38.0M
market data
Share price · 12M
$23.37 (-47.5%)
$47.33$34.64$21.95Nov 10 2025Apr 28Oct 9

Adjusted for splits and dividends.

Volume by month
$59.9M$29.9M$0Dec 2024Jun 2025Dec 2025Jun 2026Jan 2025 · sells $166KMar 2025 · buys $33.7MApr 2025 · buys $3.5MApr 2025 · sells $1.3MMay 2025 · sells $174KJun 2025 · sells $166KJul 2025 · sells $1.6MAug 2025 · sells $147KSep 2025 · buys $45.0MSep 2025 · sells $334KOct 2025 · sells $1.5MNov 2025 · sells $59.9MJan 2026 · sells $11.0MFeb 2026 · sells $458KMar 2026 · buys $8.8MMar 2026 · sells $452KApr 2026 · sells $2.9MMay 2026 · sells $588KJun 2026 · sells $5.2MJul 2026 · sells $1.0MAug 2026 · sells $193KSep 2026 · sells $3.2MOct 2026 · sells $1.9M
Buys $91.0M Sells $92.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
DR David Malcom Rodman Chief Medical Officer 19 filings · 0 buys, 19 sales JC Jon Congleton Chief Executive Officer 11 filings · 0 buys, 11 sales AL Adam Scott Levy CFO and Secretary 6 filings · 0 buys, 6 sales EW Eric Warren Chief Commercial Officer 4 filings · 0 buys, 4 sales BS Brian Taylor Slingsby Director 3 filings · 1 buy, 2 sales SA Srinivas Akkaraju Director 2 filings · 2 buys, 0 sales RP Ra Capital Management, L.P. Director 2 filings · 2 buys, 0 sales AG Alexander M Gold Director 1 filing · 0 buys, 1 sale
All 11 filers DK Daphne Karydas Director 1 filing · 0 buys, 1 sale RP RA Capital Nexus Fund III, L.P. Director 1 filing · 1 buy, 0 sales SP Samsara BioCapital, L.P. 10% owner 1 filing · 1 buy, 0 sales
Recent filings
Jon CongletonSALE Chief Executive Officer $1.9M
75,000 sh × $25.46
Exec Sep 30
Filed Oct 2 · 5:53 PM ET
Brian Taylor SlingsbySALE Director $3.0M
104,320 sh × $28.81
Exec Sep 22
Filed Sep 24 · 9:49 PM ET
Eric WarrenSALE Chief Commercial Officer $209K
7,438 sh × $28.12
Exec Sep 21
Filed Sep 22 · 6:48 PM ET
Eric WarrenSALE Chief Commercial Officer $193K
7,437 sh × $25.98
Exec Aug 21
Filed Aug 25 · 5:16 PM ET
Eric WarrenSALE Chief Commercial Officer $200K
7,438 sh × $26.87
Exec Jul 21
Filed Jul 23 · 6:39 PM ET
Jon CongletonSALE Chief Executive Officer $291K
10,700 sh × $27.24
Exec Jul 13
Filed Jul 15 · 8:58 PM ET
David Malcom RodmanSALE Chief Medical Officer $557K
20,407 sh across 2 lots
Exec Jul 13
Filed Jul 15 · 8:58 PM ET
Eric WarrenSALE Chief Commercial Officer $2.7M
104,124 sh × $25.90
Exec Jun 26
Filed Jun 30 · 5:30 PM ET
Jon CongletonSALE Chief Executive Officer $2.0M
75,000 sh across 2 lots
Exec Jun 30
Filed Jun 30 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $350K
14,474 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $152K
6,349 sh × $23.93
Exec Jun 12
Filed Jun 12 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $588K
20,404 sh across 2 lots
Exec May 12
Filed May 13 · 5:30 PM ET
Jon CongletonSALE Chief Executive Officer $422K
15,730 sh × $26.83
Exec Apr 13
Filed Apr 15 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $549K
20,406 sh across 2 lots
Exec Apr 13
Filed Apr 15 · 5:30 PM ET
Jon CongletonSALE Chief Executive Officer $2.0M
74,547 sh across 2 lots
Exec Mar 31
Filed Apr 2 · 5:30 PM ET
Ra Capital Management, L.P.PURCHASE Director $8.8M
369,000 sh across 2 lots
Exec Mar 27
Filed Mar 31 · 4:15 PM ET
David Malcom RodmanSALE Chief Medical Officer $452K
17,074 sh across 2 lots
Exec Mar 12
Filed Mar 16 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $458K
16,342 sh across 3 lots
Exec Feb 12
Filed Feb 13 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $623K
19,076 sh across 2 lots
Exec Jan 13
Filed Jan 15 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $205K
6,348 sh × $32.32
Exec Jan 12
Filed Jan 13 · 5:30 PM ET
Adam Scott LevySALE CFO and Secretary $346K
10,758 sh × $32.14
Exec Jan 12
Filed Jan 13 · 5:30 PM ET
Jon CongletonSALE Chief Executive Officer $530K
16,236 sh across 2 lots
Exec Jan 12
Filed Jan 13 · 5:30 PM ET
David Malcom RodmanSALE Chief Medical Officer $9.3M
262,752 sh across 3 lots
Exec Jan 2
Filed Jan 6 · 5:30 PM ET
Brian Taylor SlingsbySALE Director $43.4M
1,000,000 sh × $43.35
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET
Alexander M GoldSALE Director $1.5M
32,742 sh across 4 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET